| Revenue growth | Value |
|---|---|
| 3Y CAGR | +16% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +5% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,881.50 -96.70 (1.94%) | 22,759.95 | 30.96 | 5.42 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,496.10 -64.70 (2.53%) | 19,444.55 | 28.68 | 5.42 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,232.00 -183.50 (2.47%) | 18,526.25 | 109.22 | 21.23 | ||
Natco PharmaNATCOPHARM | ₹884.05 +1.65 (0.19%) | 15,806.45 | 13.81 | 1.71 |